Lady's Bedstraw (Galium verum)

Lady's Bedstraw (Galium verum) is a European herb rich in iridoids, flavonoids, and asperuloside that exerts antioxidant and cardioprotective effects. Its primary mechanisms involve scavenging reactive oxygen species and modulating inflammatory pathways to reduce oxidative cardiac damage.

Origin & History

Lady's Bedstraw (Galium verum) is a herbaceous perennial plant native to Europe and Asia. It is typically prepared as aqueous decoctions or ethanolic extracts from its aerial parts, known for being rich in flavonoids and polyphenols.

Historical & Cultural Context

Lady's Bedstraw has been used in European and Asian traditional medicine as a decoction for diuretic, anti-inflammatory, antimicrobial, and anticancer purposes. Its historical use aligns with modern preclinical findings on infections and inflammation.

Health Benefits

• Improves skin symptoms in psoriasis models (PMID: 40806422) [Preclinical evidence]. • Reduces oxidative stress and cardiac dysfunction in rat models (PMID: 39894905) [Preclinical evidence]. • Exhibits cardioprotective effects, maintaining cardiac contractility (PMID: 40806422) [Preclinical evidence]. • Inhibits cancer cell growth and protects keratinocytes from DNA damage (PMID: 24366449) [Preclinical evidence]. • Demonstrates antioxidant activity via various assays (DPPH, ABTS, FRAP) [Preclinical evidence].

How It Works

Lady's Bedstraw contains asperuloside, luteolin, and quercetin derivatives that inhibit lipid peroxidation and scavenge superoxide and hydroxyl radicals, reducing oxidative stress at the cellular level. Its flavonoids modulate NF-κB signaling to suppress pro-inflammatory cytokine release, contributing to cardioprotective outcomes. Additionally, iridoid glycosides like asperuloside may influence collagen synthesis pathways relevant to skin barrier function in psoriasis-like models.

Scientific Research

No human clinical trials or meta-analyses were identified; all evidence is preclinical, focusing on in vitro and rat models. Key studies include psoriasis and cardiovascular improvements in rats (PMIDs: 40806422, 39894905).

Clinical Summary

Current evidence for Lady's Bedstraw is limited exclusively to preclinical studies, with no published human clinical trials as of 2025. Rat model studies (PMIDs 40806422, 39894905) demonstrated reductions in oxidative stress markers and improvements in cardiac contractility parameters under induced cardiac dysfunction conditions. A psoriasis model study (PMID 40806422) reported measurable improvements in skin symptom scores alongside the cardioprotective findings. The overall evidence base is preliminary, and extrapolation to human therapeutic use requires significant caution until controlled clinical trials are conducted.

Nutritional Profile

Lady's Bedstraw (Galium verum) is a herb with limited formal nutritional analysis, but its known bioactive composition is well-characterized. Primary bioactive compounds include iridoid glycosides (asperuloside, monotropein), flavonoids (luteolin, quercetin, rutin, kaempferol — collectively estimated at 0.5–2% dry weight), and anthraquinones (alizarin, purpurin, nordamnacanthal — particularly concentrated in roots, ~1–3% dry weight). Tannins are present at approximately 3–8% dry weight, contributing astringent properties. Phenolic acids include chlorogenic acid and caffeic acid derivatives. The aerial parts contain coumarins (including umbelliferone) and saponins in trace amounts. Citric acid and gallotannins contribute to its acidic profile and historically enabled its use as a milk-curdling agent (rennet substitute), suggesting enzymatic-like protease activity. Vitamin C is present in modest amounts (estimated 10–30 mg/100g fresh weight, consistent with related Rubiaceae herbs). Silica, potassium, and calcium are the predominant minerals. Essential oils (linalool, geraniol) are present at <0.1% in aerial parts. Bioavailability: flavonoids and iridoids are generally well-absorbed via intestinal glucosidases; anthraquinones exhibit variable absorption depending on gut microbiota composition. Chlorophyll derivatives are present in green aerial parts. No standardized macronutrient (protein, fat, carbohydrate) data is available in published nutritional databases for this species, as it is used medicinally rather than as a dietary staple.

Preparation & Dosage

No clinically studied dosages in humans. Preclinical studies used topical applications and in vitro concentrations of 15-200 µg/mL. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea, turmeric, ginger, rosemary, chamomile

Safety & Interactions

No formal human safety trials for Lady's Bedstraw supplements exist, making definitive risk profiling impossible at this time. Theoretical concerns include potential interaction with anticoagulant drugs such as warfarin, given the flavonoid content which may inhibit platelet aggregation at high doses. Pregnancy and breastfeeding safety is unestablished and use should be avoided in these populations due to lack of data. Individuals with known plant allergies in the Rubiaceae family should exercise caution, and anyone on cardiac medications should consult a healthcare provider before use.